Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis
NCT00434278Phase 4Terminated
- Sponsor
- Genentech
- Start
- Mar 2007
- Primary completion
- Nov 2008
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cystic fibrosis (CF) comparing Dornase alfa with Placebo (2 arms). Primary endpoint: Change in Distance Walked in the 6-minute Walk Test at Day 14. Started Mar 2007; status: terminated.
02
Drugs
deoxyribonuclease I
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00434278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434278.